bioMérieux was LBT Innovations’ first commercial partner. In 2007 bioMérieux partnered with LBT Innovations to bring the Microstreak technology to the market. Microstreak, renamed the PREVI® Isola, was an automated system for streaking biological samples onto culture plates. Through partnership with bioMérieux, more than 500 units were sold globally sparking the initial growth of the global laboratory automation trend.
bioMérieux is a world leader in the field of in vitro diagnostics, especially microbiology, and has been for over 50 years. Providing systems, reagents and software, bioMérieux’s solutions help determine the source of disease and contamination to improve patient health and ensure consumer safety. bioMérieux is listed on the NYSE Euronext Paris market (Symbol: BIM).